{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:31:04Z","timestamp":1775871064186,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T00:00:00Z","timestamp":1536796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1038\/s41443-018-0075-x","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T16:00:35Z","timestamp":1536854435000},"page":"97-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Epalrestat, an Aldose Reductase Inhibitor, Restores Erectile Function in Streptozocin-induced Diabetic Rats"],"prefix":"10.1038","volume":"31","author":[{"given":"Bai-Bing","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Wei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei-Lei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He-Song","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Tian","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,13]]},"reference":[{"key":"75_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1743-6109.2004.10104.x","volume":"1","author":"TF Lue","year":"2004","unstructured":"Lue TF, Giuliano F, Montorsi F, Rosen RC, Andersson KE, Althof S, et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med. 2004;1:6\u201323.","journal-title":"J Sex Med"},{"key":"75_CR2","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s11892-002-0120-4","volume":"2","author":"D Richardson","year":"2002","unstructured":"Richardson D, Vinik A. Etiology and treatment of erectile failure in diabetes mellitus. Curr Diab Rep. 2002;2:501\u20139.","journal-title":"Curr Diab Rep"},{"key":"75_CR3","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1172\/JCI117406","volume":"94","author":"MJ Stevens","year":"1994","unstructured":"Stevens MJ, Dananberg J, Feldman EL, Lattimer SA, Kamijo M, Althof S, et al. The linked roles of nitric oxide, aldose reductase and, (Na\u2009+\u2009,K\u2009+\u2009)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest. 1994;94:853\u20139.","journal-title":"J Clin Invest"},{"key":"75_CR4","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/BF00282716","volume":"24","author":"R Kikkawa","year":"1983","unstructured":"Kikkawa R, Hatanaka I, Yasuda H, Kobayashi N, Shigeta Y, Althof S, et al. Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats. Diabetologia. 1983;24:290\u20132.","journal-title":"Diabetologia"},{"key":"75_CR5","doi-asserted-by":"crossref","unstructured":"Chalk C, Benstead TJ, Moore F. Aldose reductase inhibitors for the treatment of diabetic polyneuropathy. Cochrane Datab Syst Rev 2007;(4):CD004572.","DOI":"10.1002\/14651858.CD004572.pub2"},{"key":"75_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1592\/phco.28.5.646","volume":"28","author":"MA Ramirez","year":"2008","unstructured":"Ramirez MA, Borja NL. Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy. Pharmacotherapy. 2008;28:646\u201355.","journal-title":"Pharmacotherapy"},{"key":"75_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1085-9489.2006.00085.x","volume":"11","author":"M Baba","year":"2006","unstructured":"Baba M, Kimura K, Suda T, Yagihashi S, Aomori Diabetic Study G. Three-year inhibition of aldose reductase on development of symptomatic neuropathy in diabetic patients. J Peripher Nerv Syst. 2006;11:176\u20138.","journal-title":"J Peripher Nerv Syst"},{"key":"75_CR8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1006\/exnr.1997.6551","volume":"146","author":"H Sasaki","year":"1997","unstructured":"Sasaki H, Naka K, Kishi Y, Furuta M, Sanke T, Althof S, et al. The absence of synergism between the effects of an aldose reductase inhibitor, epalrestat, and a vasodilator, cilostazol, on the nerve conduction slowing and the myelinated fiber atrophy in streptozotocin-induced diabetic rats. Exp Neurol. 1997;146:466\u201370.","journal-title":"Exp Neurol"},{"key":"75_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1006\/exnr.1998.6821","volume":"151","author":"T Ohi","year":"1998","unstructured":"Ohi T, Saita K, Furukawa S, Ohta M, Hayashi K, Althof S, et al. Therapeutic effects of aldose reductase inhibitor on experimental diabetic neuropathy through synthesis\/secretion of nerve growth factor. Exp Neurol. 1998;151:215\u201320.","journal-title":"Exp Neurol"},{"key":"75_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1055\/s-0032-1333279","volume":"121","author":"O Nakagaki","year":"2013","unstructured":"Nakagaki O, Miyoshi H, Sawada T, Atsumi T, Kondo T, Althof S, et al. Epalrestat improves diabetic wound healing via increased expression of nerve growth factor. Exp Clin Endocrinol Diabetes. 2013;121:84\u20139.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"75_CR11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.2164\/jandrol.106.000794","volume":"28","author":"Y Chen","year":"2007","unstructured":"Chen Y, Yang R, Yao L, Sun Z, Wang R, Althof S, et al. Differential expression of neurotrophins in penises of streptozotocin-induced diabetic rats. J Androl. 2007;28:306\u201312.","journal-title":"J Androl"},{"key":"75_CR12","first-page":"748","volume":"11","author":"YT Dai","year":"2005","unstructured":"Dai YT, Chen Y, Yao LS, Yang R, Sun ZY, Althof S, et al. Expression of nerve growth factor in cavernous tissue and its effects on the treatment of rats with diabetic erectile dysfunction. Zhonghua Nan Ke Xue. 2005;11:748\u201351, 54.","journal-title":"Zhonghua Nan Ke Xue"},{"key":"75_CR13","doi-asserted-by":"publisher","unstructured":"Wu Y, Yang C, Meng F, Que F, Xiao W, Althof S, et al. Nerve growth factor improves the outcome of type 2 diabetes-induced hypotestosteronemia and erectile dysfunction. Reprod Sci. 2018, [Epub ahead of print]. https:\/\/doi.org\/10.1177\/1933719118773421 .","DOI":"10.1177\/1933719118773421"},{"key":"75_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.neurobiolaging.2016.11.008","volume":"50","author":"PKK Yeung","year":"2017","unstructured":"Yeung PKK, Lai AKW, Son HJ, Zhang X, Hwang O, Althof S, et al. Aldose reductase deficiency leads to oxidative stress-induced dopaminergic neuronal loss and autophagic abnormality in an animal model of Parkinson\u2019s disease. Neurobiol Aging. 2017;50:119\u201333.","journal-title":"Neurobiol Aging"},{"key":"75_CR15","doi-asserted-by":"publisher","first-page":"352","DOI":"10.2164\/jandrol.108.006999","volume":"30","author":"B Musicki","year":"2009","unstructured":"Musicki B, Ross AE, Champion HC, Burnett AL, Bivalacqua TJ. Posttranslational modification of constitutive nitric oxide synthase in the penis. J Androl. 2009;30:352\u201362.","journal-title":"J Androl"},{"key":"75_CR16","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1002\/j.1939-4640.2003.tb02743.x","volume":"24","author":"TJ Bivalacqua","year":"2003","unstructured":"Bivalacqua TJ, Usta MF, Champion HC, Kadowitz PJ, Hellstrom WJ. Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease. J Androl. 2003;24:S17\u201337.","journal-title":"J Androl"},{"key":"75_CR17","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0022-5347(17)37500-6","volume":"147","author":"KK Chen","year":"1992","unstructured":"Chen KK, Chan JY, Chang LS, Chen MT, Chan SH. Intracavernous pressure as an experimental index in a rat model for the evaluation of penile erection. J Urol. 1992;147:1124\u20138.","journal-title":"J Urol"},{"key":"75_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1745-7262.2006.00223.x","volume":"8","author":"CR Moore","year":"2006","unstructured":"Moore CR, Wang R. Pathophysiology and treatment of diabetic erectile dysfunction. Asian J Androl. 2006;8:675\u201384.","journal-title":"Asian J Androl"},{"key":"75_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/aja.1002040306","volume":"204","author":"KM McHugh","year":"1995","unstructured":"McHugh KM. Molecular analysis of smooth muscle development in the mouse. Dev Dyn. 1995;204:278\u201390.","journal-title":"Dev Dyn"},{"key":"75_CR20","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.1210\/jc.2004-0616","volume":"89","author":"HS Lim","year":"2004","unstructured":"Lim HS, Lip GY, Blann AD. Plasma von Willebrand factor and the development of the metabolic syndrome in patients with hypertension. J Clin Endocrinol Metab. 2004;89:5377\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"75_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.eururo.2008.02.034","volume":"54","author":"LX Young De","year":"2008","unstructured":"De Young LX, Domes T, Lim K, Carson J, Brock GB. Endothelial rehabilitation: the impact of chronic PDE5 inhibitors on erectile function and protein alterations in cavernous tissue of diabetic rats. Eur Urol. 2008;54:213\u201320.","journal-title":"Eur Urol"},{"key":"75_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1743-6109.2009.01541.x","volume":"7","author":"MM Garcia","year":"2010","unstructured":"Garcia MM, Fandel TM, Lin G, Shindel AW, Banie L, Althof S, et al. Treatment of erectile dysfunction in the obese type 2 diabetic ZDF rat with adipose tissue-derived stem cells. J Sex Med. 2010;7:89\u201398.","journal-title":"J Sex Med"},{"key":"75_CR23","doi-asserted-by":"publisher","first-page":"12043","DOI":"10.1073\/pnas.89.24.12043","volume":"89","author":"H Vlassara","year":"1992","unstructured":"Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Althof S, et al. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci USA. 1992;89:12043\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"75_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0031-6997(24)01347-4","volume":"50","author":"C Yabe-Nishimura","year":"1998","unstructured":"Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol Rev. 1998;50:21\u201333.","journal-title":"Pharmacol Rev"},{"key":"75_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1056-8727(02)00178-2","volume":"16","author":"N Okayama","year":"2002","unstructured":"Okayama N, Omi H, Okouchi M, Imaeda K, Kato T, Althof S, et al. Mechanisms of inhibitory activity of the aldose reductase inhibitor, epalrestat, on high glucose-mediated endothelial injury: neutrophil-endothelial cell adhesion and surface expression of endothelial adhesion molecules. J Diabetes Complicat. 2002;16:321\u20136.","journal-title":"J Diabetes Complicat"},{"key":"75_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2165\/00024677-200403040-00006","volume":"3","author":"Y Hamada","year":"2004","unstructured":"Hamada Y, Nakamura J. Clinical potential of aldose reductase inhibitors in diabetic neuropathy. Treat Endocrinol. 2004;3:245\u201355.","journal-title":"Treat Endocrinol"},{"key":"75_CR27","doi-asserted-by":"publisher","first-page":"532","DOI":"10.2165\/00002512-199303060-00007","volume":"3","author":"JW Steele","year":"1993","unstructured":"Steele JW, Faulds D, Goa KL. Epalrestat. A review of its pharmacology, and therapeutic potential in late-onset complications of diabetes mellitus. Drugs Aging. 1993;3:532\u201355.","journal-title":"Drugs Aging"},{"key":"75_CR28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0022-3565(25)21830-4","volume":"229","author":"H Terashima","year":"1984","unstructured":"Terashima H, Hama K, Yamamoto R, Tsuboshima M, Kikkawa R, Althof S, et al. Effects of a new aldose reductase inhibitor on various tissues in vitro. J Pharmacol Exp Ther. 1984;229:226\u201330.","journal-title":"J Pharmacol Exp Ther"},{"key":"75_CR29","doi-asserted-by":"publisher","first-page":"672","DOI":"10.2337\/diacare.21.4.672","volume":"21","author":"R Hayashi","year":"1998","unstructured":"Hayashi R, Hayakawa N, Makino M, Nagata M, Kakizawa H, Althof S, et al. Changes in erythrocyte sorbitol concentrations measured using an improved assay system in patients with diabetic complications and treated with aldose reductase inhibitor. Diabetes Care. 1998;21:672\u20133.","journal-title":"Diabetes Care"},{"key":"75_CR30","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","volume":"24","author":"EJ Huang","year":"2001","unstructured":"Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677\u2013736.","journal-title":"Annu Rev Neurosci"},{"key":"75_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ejphar.2006.01.047","volume":"534","author":"NA Calcutt","year":"2006","unstructured":"Calcutt NA, Freshwater JD, Hauptmann N, Taylor EM, Mizisin AP. Protection of sensory function in diabetic rats by Neotrofin. Eur J Pharmacol. 2006;534:187\u201393.","journal-title":"Eur J Pharmacol"},{"key":"75_CR32","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.juro.2006.04.020","volume":"176","author":"AL Burnett","year":"2006","unstructured":"Burnett AL, Lue TF. Neuromodulatory therapy to improve erectile function recovery outcomes after pelvic surgery. J Urol. 2006;176:882\u20137.","journal-title":"J Urol"},{"key":"75_CR33","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1111\/j.1471-4159.2004.02824.x","volume":"91","author":"T Suzuki","year":"2004","unstructured":"Suzuki T, Sekido H, Kato N, Nakayama Y, Yabe-Nishimura C. Neurotrophin-3-induced production of nerve growth factor is suppressed in Schwann cells exposed to high glucose: involvement of the polyol pathway. J Neurochem. 2004;91:1430\u20138.","journal-title":"J Neurochem"},{"key":"75_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1743-6109.2008.01194.x","volume":"6","author":"AJ Bella","year":"2009","unstructured":"Bella AJ, Lin G, Lin CS, Hickling DR, Morash C, Althof S, et al. Nerve growth factor modulation of the cavernous nerve response to injury. J Sex Med. 2009;6 Suppl 3:347\u201352.","journal-title":"J Sex Med"},{"key":"75_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jep.2010.08.055","volume":"133","author":"J Gu","year":"2011","unstructured":"Gu J, Wang JJ, Yan J, Cui CF, Wu WH, Althof S, et al. Effects of lignans extracted from Eucommia ulmoides and aldose reductase inhibitor epalrestat on hypertensive vascular remodeling. J Ethnopharmacol. 2011;133:6\u201313.","journal-title":"J Ethnopharmacol"},{"key":"75_CR36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/1056-8727(96)00113-4","volume":"10","author":"N Hotta","year":"1996","unstructured":"Hotta N, Sakamoto N, Shigeta Y, Kikkawa R, Goto Y. Clinical investigation of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy in Japan: multicenter study. Diabetic Neuropathy Study Group in Japan. J Diabetes Complicat. 1996;10:168\u201372.","journal-title":"J Diabetes Complicat"},{"key":"75_CR37","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.2337\/dc05-2370","volume":"29","author":"N Hotta","year":"2006","unstructured":"Hotta N, Akanuma Y, Kawamori R, Matsuoka K, Oka Y, Althof S, et al. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative aldose reductase inhibitor-diabetes complications trial. Diabetes Care. 2006;29:1538\u201344.","journal-title":"Diabetes Care"},{"key":"75_CR38","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1111\/j.1464-5491.2012.03684.x","volume":"29","author":"N Hotta","year":"2012","unstructured":"Hotta N, Kawamori R, Fukuda M, Shigeta Y, Aldose Reductase Inhibitor-Diabetes Complications Trial Study G. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy. Diabet Med. 2012;29:1529\u201333.","journal-title":"Diabet Med"}],"updated-by":[{"DOI":"10.1038\/s41443-018-0106-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000}}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0075-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0075-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0075-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T05:49:43Z","timestamp":1751867383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-018-0075-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,13]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["75"],"URL":"https:\/\/doi.org\/10.1038\/s41443-018-0075-x","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41443-018-0106-7","asserted-by":"object"}]},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,13]]},"assertion":[{"value":"10 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This Article was originally published under Nature Research\u2019s License to Publish, but has now been made available under a CC BY 4.0 license. The PDF and HTML versions of the Article have been modified accordingly.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}